Jupyter Notebook is a tool to run and write Python code easily, showing results right away, and allowing you to combine code, charts, notes, and files in one place. You can start Jupyter Notebook ...

On a Sunday night last fall, around 20 of Kamala Harris’s close friends (and Spike Lee) gathered in the private dining room of Beefbar, an upscale restaurant in Tribeca. The former vice president was ...

A Des Moines running club is being required by the city to pay over $4,300 in permit fees to use a public park. The 515 Run Club, which is free and informal, argues the fees are unjust as they use ...

Connecticut prosecutors and police chiefs have put the brakes on the rapidly expanding acquisition by police agencies of artificial intelligence-powered law enforcement tools until the emerging ...

MIAMI — A Miami woman is facing serious felony charges over what police said was a racially-motivated pair of attempts to run over a mail carrier. Miami police said it happened on Tuesday around 4:25 ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

Valve already collects a lot of data about your gaming PC, typically to release its hardware survey every month. But it looks like Steam will soon use frame rate data gathered by its millions of users ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

Anthropic (ANTHRO) is on track to generate nearly $20B in annual revenue, more than doubling its run rate from $9B at the end of 2025, driven by strong adoption of its AI models and products such as ...

The Seattle Times’ Education Lab examines the educational system from early childhood through post-secondary. Education Lab is supported by Gates Foundation, Ballmer Group and The Norcliffe Foundation ...

Amgen’s decision to terminate its rocatinlimab collaboration with Kyowa Kirin follows the publication of data on Sanofi’s rival OX40 drug candidate amlitelimab. (iStock / Getty Images Plus) Amgen has ...